Qingdao Vland Biotech INC. (SHA:603739)

China flag China · Delayed Price · Currency is CNY
14.98
+0.26 (1.77%)
Apr 29, 2026, 3:00 PM CST
20.42%
Market Cap 3.79B
Revenue (ttm) 1.37B
Net Income (ttm) 69.81M
Shares Out 253.03M
EPS (ttm) 0.28
PE Ratio 53.50
Forward PE n/a
Dividend 0.10 (0.68%)
Ex-Dividend Date May 30, 2025
Volume 4,485,750
Average Volume 4,200,820
Open 14.68
Previous Close 14.72
Day's Range 14.52 - 15.10
52-Week Range 12.23 - 18.41
Beta 0.53
RSI 49.71
Earnings Date Apr 25, 2026

About SHA:603739

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antivir... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 1,535
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603739
Full Company Profile

Financial Performance

In 2025, SHA:603739's revenue was 1.37 billion, an increase of 3.43% compared to the previous year's 1.32 billion. Earnings were 69.81 million, an increase of 11.45%.

Financial Statements

News

There is no news available yet.